BridgeBio Pharma Inc.
BBIO | NASDAQ
$75.80
+$0.85 (+1.13%)
Nov 2, 2026, 12:21 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | -724.93M | -543.35M | -643.2M | -484.65M | -586.45M | -505.49M |
Depreciation & Amortization | 5.43M | 6.08M | 6.49M | 6.77M | 5.84M | 1.46M |
Stock-Based Compensation | 133.02M | 95.8M | n/a | 91.56M | 99.51M | 58.46M |
Other Working Capital | 82.36M | 33.5M | -13.05M | 13.26M | -7.23M | 15.67M |
Other Non-Cash Items | 191.63M | -111.3M | 103.93M | -61.25M | 18.5M | 32.79M |
Deferred Income Tax | n/a | n/a | n/a | n/a | -30.93M | -1.87M |
Change in Working Capital | -51.06M | 32.04M | 5.06M | 28.08M | -4.4M | 14.93M |
Operating Cash Flow | -445.91M | -520.73M | -527.72M | -419.49M | -497.93M | -399.71M |
Capital Expenditures | -1.1M | -933K | -1.31M | -6.32M | -48.25M | -7.52M |
Cash Acquisitions | n/a | -140K | n/a | n/a | -35M | 21.24M |
Purchase of Investments | -28.2M | -88.4M | -137.26M | -193.06M | -643.28M | -287.85M |
Sales Maturities Of Investments | 11M | 158.23M | 193.11M | 532.52M | 477.04M | 242.23M |
Other Investing Acitivies | -6.19M | -7.98M | -503K | 118.5M | 48.65M | -21.09M |
Investing Cash Flow | -24.49M | 60.78M | 54.03M | 453.15M | -200.83M | -52.99M |
Debt Repayment | 385.5M | 476.58M | n/a | -20.49M | 1.08B | 550M |
Common Stock Repurchased | -48.28M | -7.53M | -6.88M | -1.56M | -204.75M | -75.71M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -12.08M | -35.34M | 8.61M | 4.06M | -138.49M | -27.1M |
Financial Cash Flow | 359.29M | 748.46M | 451.54M | -13.13M | 736.45M | 447.19M |
Net Cash Flow | -111.1M | 288.51M | -22.15M | 20.52M | 37.69M | -5.52M |
Free Cash Flow | -447.01M | -521.66M | -529.03M | -425.82M | -546.18M | -407.23M |
Adj. Free Cash Flow | -580.03M | -617.46M | -529.03M | -517.37M | -645.69M | -465.69M |
Maintenance CapEx | n/a | n/a | -1.31M | -1.64M | -1.34M | -7.52M |
Growth CapEx | -1.1M | -933K | n/a | -4.68M | -46.91M | n/a |
Owner Earnings | -445.91M | -520.73M | -529.03M | -421.14M | -499.27M | -407.23M |
Add to Watchlist
Select watchlists to add or remove BBIO